Skip to main content

Table 3 Optical coherence tomography measurements

From: Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

 

Overall (n = 60)

DM (n = 37)

Non-DM (n = 23)

P value (DM vs. non-DM)

OCT follow-up duration (days)

277 ± 69

287 ± 77

261 ± 51

0.16

Mean stent area (mm2)

6.7 ± 1.9

6.3 ± 1.8

7.2 ± 1.9

0.063

Mean minimum stent area (mm2)

5.3 ± 1.8

5.0 ± 1.7

5.8 ± 1.7

0.073

Mean SEI

0.89 ± 0.03

0.90 ± 0.03

0.88 ± 0.02

0.060

Average of minimum SEI

0.79 ± 0.07

0.79 ± 0.07

0.78 ± 0.06

0.52

Mean lumen area (mm2)

6.1 ± 1.9

5.7 ± 1.77

6.7 ± 1.9

0.051

Mean number of struts

271 ± 112

292 ± 124

237 ± 83

0.070

Mean number of uncovered struts

2.2 ± 2.9

2.4 ± 3.2

1.9 ± 2.2

0.47

Frequency of uncovered struts (%)

0.78

0.79

0.78

0.97

Mean neointimal thickness (µm)

82 ± 35

86 ± 36

75 ± 33

0.28

Mean neointima area (mm2)

0.63 ± 0.31

0.65 ± 0.29

0.61 ± 0.35

0.60

Average of max neointimal thickness (µm)

350 ± 180

420 ± 180

380 ± 150

0.44

Variability in neointima thickness

67 ± 26

73 ± 29

59 ± 18

0.060

Frequency of stent with in-stent thrombi

5 (8.3)

5 (13.5)

0 (0.0)

0.080

  1. Values are mean ± standard deviation or number (%)
  2. OCT optical coherence tomography, SEI stent eccentricity index